Search Results "#MEKInhibitors"

Blogs

arrow_forward View More Results
MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
Posted by Surbhi on July 10 2026 at 05:32 PM   public
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringW...
arrow_forward